Search Results
Results found for "pain modeling"
- Atypical Structure and Function of Typical Chemokine Receptors
laboratory is to understand the physiological consequences of NMDA receptor deficiency using genetic mouse models
- Seeking to gain more knowledge on signaling bias? We’ve got the perfect opportunity for you 🚀 Registrations open until February 14th ⚠️ Last spots available for “The Practical Assessment of Signaling Bias” with Dr. Terry Kenakin ✳️Register today at https://www.ecosystem.drgpcr.com/event-details-registration/the-practical-assessment-of-signaling-bias #gpcr #drgpcr | Dr. GPCR Ecosystem
Home → Flash News → Seeking to gain more knowledge on signaling bias? GPCR Courses Seeking to gain more knowledge on signaling bias?
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
mechanism through which rare genetic variation may lead to or protecting from excessive body weight gain Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
CD97 in glioblastoma Dimitris Placantonakis Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation out Ryk, required for Vangl2 function, protected synapses and preserved cognitive function in a mouse model Collectively, these data suggest that ADCs targeting CD97 impair tumor growth in preclinical GBM models Placantonakis Lab Google Scholar LinkedIn Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain (biochemistry, cell biology, genetics) and experimental systems (purified proteins, cultured cells, model Garcia-Marcos's academic journey, which spans training in Spain, Belgium, and a postdoctoral fellowship
- GPCR Retreat Schedule 2023
University of Toronto Read More Friday, November 3rd / 9:45 AM Pharmacological and Genetic Preclinical Models More Friday, November 3rd / 11:05 AM Biased agonism at the GLP-1 receptor: from structure to animal models Federal University of Minas Gerais, Brazil Read More Friday, November 3rd / 1:55 PM A positive Allosteric Modulator
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
There she focused on the different modes of action of Adhesion GPCRs and found that they do not only different signals on a molecular level and how these are translated into physiological functions in various model
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities larval growth and embryonic development in the multivoltine strain of Bombyx more Profiling Allosteric Modulators GPCRs in Neuroscience Cortical astrocyte activation triggers meningeal nociception and migraine-like pain β-arrestin-1/endothelin axis in human ovarian fibroblasts Methods & Updates in GPCR Research Histamine-modulated
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before credible GPCR CROs and expert consultants 📚 Train and upskill your team with specialized programs 📢 Gain Gain confidence and direction with a customized roadmap aligned to your biotech’s goals and timeline Gain clarity and direction to move your biotech forward—faster and smarter. → Explore Timeline Strategy
- 🚨 Exciting Opportunity for Professionals in Drug Development! 🚨 Register today for a one-of-a-kind online course at Dr. GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 ⏰ Time: Thursdays, 10:00 AM - 11:30 AM (EST) This advanced course is essential for anyone working in drug development and focuses on: The essentials of new drug development Key pharmacokinetic elements (absorption, distribution, clearance) Hepatic metabolism and the Cytochrome P450 system Drug safety and toxicology (including drug-drug interactions) And much more! Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to bring therapeutic molecules to life. 🚨 Only 25 spots available — register now! 💡 This is a great opportunity for both academia and industry professionals. Sessions will be live, and you’ll also have 1:1 discussion time with the instructor. Full PDFs of the slides will be available! 🔗 https://buff.ly/lVEcRUc #GPCR #DrugDevelopment #Pharmacokinetics #TherapeuticDrugs #OnlineCourse #DrGPCRUniversity #PharmaceuticalIndustry | Dr. GPCR Ecosystem
Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to
- How GPCR Collaboration Built an Innovation Engine | Dr. GPCR Ecosystem
Monash Institute of Pharmaceutical Sciences, a quiet experiment challenged the traditional PI-silo model
- Lighting up a native pancreatic islet isn’t just a technical win it’s a shift in what GPCR imaging can reveal | Dr. GPCR Ecosystem
deep-imaging setups A design logic that extends to other GPCRs Just as important: the collaboration model
- ama session sept 18 post 1 | Dr. GPCR Ecosystem
Join Terry’s Corner AMA to master GPCR signaling, allosteric modulation, and kinetic strategy in drug In the discovery phase, one overlooked kinetic parameter or a misjudged model can set your team back learn how to: Decode GPCR signaling complexity using functional assay strategies Identify allosteric modulators
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
validation in GPCR assay design Building reagents that must work in complex tissues, not just simplified models chemistry from the University of Bari in 2018, including research training at the CIQUS Research Center in Spain Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through
- Lauren Celano | Dr. GPCR Ecosystem
Working in a lab allows scientists to gain amazing hard and soft skills, which opens the doors to several
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
My main topics were protein biochemistry, Drosophila husbandry, and genetics. Since then, I have broadened my horizons with many more techniques in vivo and in vitro, with a main
- Dr. Debbie Hay | Dr. GPCR Ecosystem
She has gained experience from working in academia and at GSK as an industrial trainee.
- ama session sept 18 post 3 | Dr. GPCR Ecosystem
fast-changing field: “Try to keep a finger on the pulse of as much as you can… that was one of the main
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Receptors and Hearing and Balance Receptors Bill Huang Self-Cleavage of GPR110 SEA Domain and Its Impact on GAIN adhesion GPCR Signaling and Pharmacology-Enabling Drug Discovery Fabian Pohl Structural Determinants Of GAIN Caroline Formstone Interrogating The Role Of CELSR1 (ADGRC1) In Breast Cancer Mariam Melkumyan GPR110 modulates TNIK Sumit Bandekar Structural studies of the CELSR1 extracellular region reveal a compact multidomain module regulates signaling Nicole Perry-Hauser Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation
- Dr. Terry Hébert | Dr. GPCR Ecosystem
and his team are working on understanding receptor signaling in specialized cellular environments to gain
- Dr. Alexander S. Hauser | Dr. GPCR Ecosystem
structural biology, pharmacology, and pharmacoepidemiology with innovative computational methods to gain
- Did you know? 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! 🧬💡 These innovative compounds, “Photo-BQCisA” and “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors (M1-M5). 🔬✨ Learn more about this breakthrough in the Ecosystem! | Dr. GPCR Ecosystem
🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! compounds, “Photo-BQCisA” and “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! compounds, “Photo-BQCisA” and “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
His main research group centers on the function, structure, and regulation of G protein-coupled receptors
- A journey from Duke to McGill along the dopamine circuit
At McGill, his laboratory has two main axes of research: 1) Studying interindividual vulnerability to
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
GPCR About Ben Holland "Ben gained his masters in Engineering Science from Oxford, taking a specialisation
- GPCR Retreat | Dr. GPCR Ecosystem
The main goal of the GPCR Retreat is to provide a venue for students, post-doctoral fellows, and principal
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
Berchiche About this episode Listen to this fantastic round table discussion that I had the privilege to moderate provide an ideal case study for quantitative, and multi‐scale integration of these amounts of data to gain
- Dr. Timo De Groof | Dr. GPCR Ecosystem
During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and gained
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors


















